Compounds > marimastat
Page last updated: 2024-09-03

marimastat and varespladib

marimastat has been researched along with varespladib in 1 studies

Compound Research Comparison

Studies
(marimastat)		Trials
(marimastat)		Recent Studies (post-2010)
(marimastat)		Studies
(varespladib)		Trials
(varespladib)		Recent Studies (post-2010) (varespladib)
2152853801149

Protein Interaction Comparison

ProteinTaxonomymarimastat (IC50)varespladib (IC50)
Group 10 secretory phospholipase A2Homo sapiens (human)0.0918
85/88 kDa calcium-independent phospholipase A2Homo sapiens (human)0.2944
Phospholipase A2, major isoenzymeSus scrofa (pig)0.048
Phospholipase A2Homo sapiens (human)0.3668
Phospholipase A2, membrane associatedHomo sapiens (human)0.0527
Phospholipase A2, membrane associatedMus musculus (house mouse)0.07
Phospholipase A2 group VHomo sapiens (human)0.2738
Phospholipase A2 group VMus musculus (house mouse)0.75
Putative inactive group IIC secretory phospholipase A2Homo sapiens (human)0.1225
Group XIIB secretory phospholipase A2-like proteinHomo sapiens (human)0.1225
Group XIIA secretory phospholipase A2Homo sapiens (human)0.1225
Group IIF secretory phospholipase A2Homo sapiens (human)0.125
Group 3 secretory phospholipase A2Homo sapiens (human)0.1225
Group IIE secretory phospholipase A2Homo sapiens (human)0.0862
Group IIE secretory phospholipase A2Mus musculus (house mouse)0.075
Group 10 secretory phospholipase A2Mus musculus (house mouse)0.075
Group IID secretory phospholipase A2Homo sapiens (human)0.1017
Group IID secretory phospholipase A2Mus musculus (house mouse)0.43
Phospholipase A2Mus musculus (house mouse)0.14

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Carter, R; Chowdhury, A; Fry, BG; Lewin, MR; Zdenek, CN1

Other Studies

1 other study(ies) available for marimastat and varespladib

ArticleYear
The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (
    Frontiers in immunology, 2021, Volume: 12

    Topics: Acetates; Africa; Animals; Antivenins; Enzyme Inhibitors; Hydroxamic Acids; In Vitro Techniques; Indoles; Keto Acids; Naja; Organic Chemicals; Snake Bites; Snake Venoms

2021